Syndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company, will participate in the Goldman Sachs 45th Annual Global Healthcare Conference. CEO Michael A. Metzger will join a fireside chat on June 12, 2024, at 8:40 a.m. ET. The event will be webcast live on the company's website, with a replay available for a time.

Positive

• Participation in a high-profile event like the Goldman Sachs Annual Global Healthcare Conference increases visibility and prestige.
• CEO Michael A. Metzger's involvement may boost investor confidence in Syndax's leadership.
• The webcast accessibility allows a broader audience to engage with the company's strategic plans and updates.

Negative

• No direct information or updates about clinical trial progress or financial performance were provided.
• The event's impact on stock price is uncertain without substantive news or results announced.

WALTHAM, Mass., June 5, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024, at 8:40 a.m. ET.

A live webcast of the fireside chat can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective menin inhibitor, and axatilimab, a monoclonal antibody that blocks the CSF-1 receptor. For more information, please visit www.syndax.com or follow the Company on X (formerly Twitter) and LinkedIn.

Syndax Contact
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

View original content:https://www.prnewswire.com/news-releases/syndax-announces-participation-at-the-goldman-sachs-45th-annual-global-healthcare-conference-302163121.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

What event will Syndax Pharmaceuticals participate in on June 12, 2024?

Syndax Pharmaceuticals will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference.

Who will represent Syndax Pharmaceuticals at the Goldman Sachs 45th Annual Global Healthcare Conference?

Michael A. Metzger, Chief Executive Officer of Syndax Pharmaceuticals, will represent the company.

How can I access the live webcast of Syndax Pharmaceuticals' presentation at the Goldman Sachs conference?

The live webcast can be accessed from the Investor section of Syndax's website, with a replay available for a time.

What is the stock symbol for Syndax Pharmaceuticals?

The stock symbol for Syndax Pharmaceuticals is SNDX.